Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11970839rdf:typepubmed:Citationlld:pubmed
pubmed-article:11970839lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:11970839lifeskim:mentionsumls-concept:C0022181lld:lifeskim
pubmed-article:11970839lifeskim:mentionsumls-concept:C0036733lld:lifeskim
pubmed-article:11970839lifeskim:mentionsumls-concept:C1151146lld:lifeskim
pubmed-article:11970839pubmed:issue1lld:pubmed
pubmed-article:11970839pubmed:dateCreated2002-4-23lld:pubmed
pubmed-article:11970839pubmed:abstractTextThe calcium-specific ionophore ionomycin triggers neutrophils to activate their NADPH oxidase and generate reactive oxygen species. This activation is restricted to intracellular sites and involves the neutrophil granules. Cells that have experienced an ionomycin-induced rise in intracellular calcium will also mobilize their intracellular granules and are primed to subsequent challenge with the chemoattractant formylmethionyl-leucyl-phenylalanine (fMLF), but have lost their ability to become desensitized to the same agonist. We have investigated the involvement of serine proteases in the calcium-induced effector functions using the inhibitor diisopropyl fluorophosphate (DFP). The ionomycin-induced NADPH oxidase activity was abrogated by the protease inhibitor, whereas the activity induced by fMLF was unaffected. The DFP-dependent inhibition was restricted to the NADPH oxidase activity, as all other ionomycin-induced cellular activities were largely unaffected. We thus suggest that a serine protease is of importance for the calcium ionophore-induced signal(s) to reach and activate the dormant NADPH oxidase in the neutrophil granules.lld:pubmed
pubmed-article:11970839pubmed:languageenglld:pubmed
pubmed-article:11970839pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11970839pubmed:citationSubsetIMlld:pubmed
pubmed-article:11970839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11970839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11970839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11970839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11970839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11970839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11970839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11970839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11970839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11970839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11970839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11970839pubmed:statusMEDLINElld:pubmed
pubmed-article:11970839pubmed:monthFeblld:pubmed
pubmed-article:11970839pubmed:issn1523-0864lld:pubmed
pubmed-article:11970839pubmed:authorpubmed-author:DahlgrenClaes...lld:pubmed
pubmed-article:11970839pubmed:authorpubmed-author:KarlssonAnnaAlld:pubmed
pubmed-article:11970839pubmed:issnTypePrintlld:pubmed
pubmed-article:11970839pubmed:volume4lld:pubmed
pubmed-article:11970839pubmed:ownerNLMlld:pubmed
pubmed-article:11970839pubmed:authorsCompleteYlld:pubmed
pubmed-article:11970839pubmed:pagination17-25lld:pubmed
pubmed-article:11970839pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:meshHeadingpubmed-meshheading:11970839...lld:pubmed
pubmed-article:11970839pubmed:year2002lld:pubmed
pubmed-article:11970839pubmed:articleTitleIonomycin-induced neutrophil NADPH oxidase activity is selectively inhibited by the serine protease inhibitor diisopropyl fluorophosphate.lld:pubmed
pubmed-article:11970839pubmed:affiliationThe Phagocyte Research Laboratory, Department of Rheumatology, University of Göteborg, Göteborg, Sweden. Claes.Dahlgren@microbio.gu.selld:pubmed
pubmed-article:11970839pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11970839pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:27035entrezgene:pubmedpubmed-article:11970839lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11970839lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11970839lld:pubmed